A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis
Clinical trial NCT03682705 · COMPLETED
Trial details
- NCT number
- NCT03682705
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-08
- Primary completion
- 2020-03-26
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.